Nicolab
PrivateLast Round
Strategic
Apr 4, 2024
Est. Valuation
$140M
Total Funding Raised
$14.11M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Nicolab operates in Healthcare & Life Sciences and is based in Amsterdam. Its latest recorded funding round was a Grant round in February 2023.
Nicolab is a medtech company that provides StrokeViewer, an AI-powered platform designed to streamline emergency workflows and improve stroke diagnosis and treatment.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Vertical SaaS, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nicolab Comparables
Compare Nicolab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RapidAI | 90% | |
| Brainomix | 88% | |
| Methinks AI | 87% |
For institutional investors. Book with your work email.
Nicolab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Apr 4, 2024 | ||||
| VC Round | Dec 4, 2023 | ||||
| Grant | Feb 20, 2023 | ||||
| Series A | Apr 21, 2021 | ||||
| Grant | Jul 18, 2019 | ||||
Grant | Jul 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Nicolab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fifth Estate Asset Management | Series A |
| European Innovation Council Fund | Grant |
| Canaccord Genuity | Series A |
| Regal Partners | Series A |
| Ellerston Capital | Series A |
| Perennial Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 75% MoM, reaching 3.8K.
- Jul 26, 2026
Monthly visitors increased 60% MoM, reaching 2.2K.
For institutional investors. Book with your work email.
Nicolab Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nicolab's valuation, stock price, and market status.
Is Nicolab a public or private company?
Nicolab is a private company.
What is the current stock price of Nicolab?
Nicolab is a private company, so its shares have no public market price. Caplight tracks Nicolab's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nicolab worth (valuation)?
Nicolab's valuation is estimated at $140.0M based on funding round data.
Can I buy Nicolab stock?
Nicolab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nicolab's last funding round?
Nicolab's most recent funding round was Strategic on April 4, 2024.
Who are the main investors in Nicolab?
Key investors in Nicolab include European Innovation Council Fund, Canaccord Genuity.
Will Nicolab IPO soon?
No public IPO plans have been announced for Nicolab.
How can I track Nicolab secondary market activity?
Caplight tracks bids, offers, and trades in Nicolab's shares on secondary markets.